Synthesis & Characterization of a Tuberculosis Vaccine

Award Information
Agency:
Department of Health and Human Services
Branch:
N/A
Amount:
$133,000.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43AI056880-01A1
Agency Tracking Number:
AI056880
Solicitation Year:
2004
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Small Business Information
ANCORA PHARMACEUTICALS
ANCORA PHARMACEUTICALS, 700 HURON AVE, #18K, CAMBRIDGE, MA, 02138
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
N/A
Principal Investigator
 OBADIH Plante
 (781) 395-7700
 OPLANTE@ANCORAPHARMA.COM
Business Contact
 JOHN PENA
Phone: (617) 354-0863
Email: JPENA@ANCORAPHARMA.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Tuberculosis (TB) has plagued mankind for millennia. While several drugs and vaccine strategies have been developed to counter the TB, it remains a major infectious cause of morbidity and mortality worldwide. 1.Thoug

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government